AMP Adds to Lipocine Position and Starts Position in Cara Therapeutics for Hypothetical Fund


This past week AMP increased it's position in Lipocine Inc. (LPCN) by adding an additional 6,964 shares at $3.59/share. This transaction doubles AMP's position in LPCN bringing it up to $50K in invested funds.

AMP also started a position in Cara Therapeutics (CARA) by purchasing 1,258 shares at $19.88/share for a transaction totaling ~$25K. Cara Therapeutics is a clinical-stage located in Stamford, CT developing and commercializing new chemical entities designed to change the way acute pain, chronic pain and pruritus are managed.


0 comments